Next-Generation Therapies for Metastatic HR-Positive Breast Cancer

This is Part 3 of Next-Generation Therapies for Metastatic Hormone Receptor–Positive Breast Cancer: Where Are We Headed?, a three-part video roundtable series. Scroll down to watch the other videos fr...

breast cancer

/ Next-Generation Therapies for Metastatic HR-Positive Breast Cancer

PIK3CA-Mutated Metastatic Breast Cancer

This is Part 2 of Next-Generation Therapies for Metastatic HR-Positive Breast Cancer: Where Are We Headed?, a three-part video roundtable series. Scroll down to watch the other videos from this roundt...

breast cancer

/ Next-Generation Therapies for Metastatic HR-Positive Breast Cancer

ESR1-Mutated Metastatic Breast Cancer

This is Part 1 of Next-Generation Therapies for Metastatic HR-Positive Breast Cancer: Where Are We Headed?, a three-part video roundtable series. Scroll down to watch the other videos from this roundt...

Oct

Today In Oncology

Next-Generation Therapies for Metastatic HR-Positive Breast Cancer

Endocrine-Resistant Metastatic Breast Cancer

PIK3CA-Mutated Metastatic Breast Cancer

ESR1-Mutated Metastatic Breast Cancer

National Academy of Medicine Elects 100 New Members

SBRT vs Conventional Radiotherapy for Localized Prostate Cancer

Mutations and DNA Structures May Drive Urothelial Carcinoma

Impact of Hormonal Contraception on Breast Cancer Risk in BRCA1/2 Germline Mutation Carriers

I-SPY2.2: Dato-DXd Plus Durvalumab Yields High Pathologic Response Rate in Breast Cancer Subset